Literature DB >> 21395878

Effect of Lactobacillus paracasei ST11 on a nasal provocation test with grass pollen in allergic rhinitis.

J Wassenberg1, S Nutten, R Audran, N Barbier, V Aubert, J Moulin, A Mercenier, F Spertini.   

Abstract

BACKGROUND: Probiotics have been associated with prevention and improvement of symptoms in atopic diseases such as atopic dermatitis. However, few studies exist that document their efficacy for upper airways allergies such as allergic rhinitis.
OBJECTIVE: To investigate the effect of short-term oral administration of Lactobacillus paracasei ST11 on a nasal provocation test (NPT) with grass pollen.
METHODS: Thirty-one adult volunteers with allergic rhinitis were enrolled in a randomized, double-blind, placebo-controlled study, based on two 4-week cross-over periods of product consumption (ST11-fermented milk vs. placebo), separated by a wash-out period of 6-8 weeks. Objective and subjective clinical parameters of NPT as well as systemic and nasal immunological parameters were compared between the two treatment periods (registration number: NCT 011 50 253).
RESULTS: Subjects that received ST11-fermented milk had lower nasal congestion than subjects under placebo (visual analogical scale; P<0.05). Nasal pruritus followed the same trend. However, no significant change in combined nasal reaction threshold was observed between the two periods. IL-5 secretion by peripheral blood mononuclear cells and serum allergen-specific IgG4 were significantly lower in ST11-fermented milk group compared to placebo group. IL-8 and IL-10 secretion followed the same trend. CONCLUSION AND CLINICAL RELEVANCE: Short-term treatment with ST11-fermented milk before NPT significantly improved a clinical marker of NPT (subjective nasal congestion) and down-regulated systemic immune markers (IL-5 from peripheral blood mononuclear cells and serum IgG4). These data strongly suggest that probiotics may down modulate key parameters of allergic rhinitis and warrant future evaluation in seasonal trials.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21395878     DOI: 10.1111/j.1365-2222.2011.03695.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  20 in total

1.  Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: a double-blind, randomized, placebo-controlled trial (GA2LEN Study).

Authors:  D J Costa; P Marteau; M Amouyal; L K Poulsen; E Hamelmann; M Cazaubiel; B Housez; S Leuillet; M Stavnsbjerg; P Molimard; S Courau; J Bousquet
Journal:  Eur J Clin Nutr       Date:  2014-02-26       Impact factor: 4.016

2.  rBet v 1 immunotherapy of sensitized mice with Streptococcus thermophilus as vehicle and adjuvant.

Authors:  Claudia Petrarca; Emanuela Clemente; Valentina Toto; Manuela Iezzi; Cosmo Rossi; Stefania Zanotta; Gianni Mistrello; Ivan Zanoni; Francesca Granucci; Stefania Arioli; Diego Mora; Simone Guglielmetti; Roberto Paganelli; Mario Di Gioacchino
Journal:  Hum Vaccin Immunother       Date:  2014-03-06       Impact factor: 3.452

Review 3.  The impact of bacterial infection on mast cell degranulation.

Authors:  Jordan Wesolowski; Fabienne Paumet
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

4.  Intragastric and Intranasal Administration of Lactobacillus paracasei NCC2461 Modulates Allergic Airway Inflammation in Mice.

Authors:  Céline Pellaton; Sophie Nutten; Anne-Christine Thierry; Caroline Boudousquié; Nathalie Barbier; Carine Blanchard; Blaise Corthésy; Annick Mercenier; François Spertini
Journal:  Int J Inflam       Date:  2012-03-21

5.  Clinical Use of Probiotics in Pediatric Allergy (CUPPA): A World Allergy Organization Position Paper.

Authors:  Alessandro Fiocchi; Wesley Burks; Sami L Bahna; Leonard Bielory; Robert J Boyle; Renata Cocco; Sten Dreborg; Richard Goodman; Mikael Kuitunen; Tari Haahtela; Ralf G Heine; Gideon Lack; David A Osborn; Hugh Sampson; Gerald W Tannock; Bee Wah Lee
Journal:  World Allergy Organ J       Date:  2012-11       Impact factor: 4.084

6.  Comparison of two oral probiotic preparations in a randomized crossover trial highlights a potentially beneficial effect of Lactobacillus paracasei NCC2461 in patients with allergic rhinitis.

Authors:  Yannick Perrin; Sophie Nutten; Régine Audran; Bernard Berger; Rodrigo Bibiloni; Jacqueline Wassenberg; Nathalie Barbier; Vincent Aubert; Julie Moulin; Anurag Singh; Corinne Magliola; Annick Mercenier; François Spertini
Journal:  Clin Transl Allergy       Date:  2014-01-06       Impact factor: 5.871

7.  Immunomodulatory Activity of Lactococcus lactis A17 from Taiwan Fermented Cabbage in OVA-Sensitized BALB/c Mice.

Authors:  Hui-Ching Mei; Yen-Wenn Liu; Yi-Chin Chiang; Shiou-Huei Chao; Nai-Wen Mei; Yu-Wen Liu; Ying-Chieh Tsai
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-21       Impact factor: 2.629

Review 8.  Treatment of allergic rhinitis with probiotics: an alternative approach.

Authors:  Gui Yang; Zhi-Qiang Liu; Ping-Chang Yang
Journal:  N Am J Med Sci       Date:  2013-08

9.  Oral administration of Lactobacillus paracasei NCC 2461 for the modulation of grass pollen allergic rhinitis: a randomized, placebo-controlled study during the pollen season.

Authors:  Chiara Nembrini; Anurag Singh; Carlos Antonio De Castro; Annick Mercenier; Sophie Nutten
Journal:  Clin Transl Allergy       Date:  2015-12-09       Impact factor: 5.871

10.  Effect of type of TAG fatty acids on lutein and zeaxanthin bioavailability.

Authors:  Béatrice Gleize; Franck Tourniaire; Laurence Depezay; Romain Bott; Marion Nowicki; Lionel Albino; Denis Lairon; Emmanuelle Kesse-Guyot; Pilar Galan; Serge Hercberg; Patrick Borel
Journal:  Br J Nutr       Date:  2012-12-11       Impact factor: 3.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.